INS and metabolic syndrome: Among current ART regimens, INSTIs used with TAF appear to have the most significant impact on metabolic disturbances by increasing insulin resistance, which over the years, promotes the evolution of metabolic syndrome components, eventually triggering inflammatory processes, accelerating ageing, and leading to steatohepatitis.